Endocrinology of women sexual health

Abstract

The role of endocrine factors in general maintenance of female sexuality in different ages, sexual dysfunctions associated with endocrine disorders, their treatment and preventive measures are considered in the article. The attention was also concentrated to the effects of oral contraception and therapy with oestrogen and testosteron for women sexuality.

Keywords

female sexual dysfunction / decreased sexual desire / menopause / dyspareunia / androgen deficiency / endocrine disorders / contraception

References

[1] A linkage between DNA markers on the X-chromosome and male orientation / Hamer D. H. [et al.] // Science. — 1993. — Vol. 261. — P. 3212–3329.

[2] Androgen glucuronides, instead testosterone, as the new markers of androgenic activity in women / Labrie F. [et al.] // Journal Steroid. Biohem. Mol. Biol. — 2006. — Vol. 99. — P. 182–188.

[3] Androgen levels in adult females: changes with age, menopause and oophorectomy / Devison S. L. [et al.] // J. Clin. Endocrinol. Metab. — 2005. — Vol. 90. — P. 3847–3853.

[4] Androgen therapy in women: an Endocrine Society Practice Guideline / Wiermann M. [et al.] // J. Clin. Endocrinol. Metab. — 2006. — Vol. 91. — P. 3697–3710.

[5] Androgens and sexual behavior in women using oral contraceptives / Bancroft J. [et al.] // Clinical Endocrinology. — 1980. — Vol. 12. — P. 327–340.

[6] Bancroft J. The endocrinology of sexual arousal // J. Endocrinol. — 2005. — Vol. 186. — P. 411–422.

[7] Bhasin S. Female androgen deficiency syndrome — an unproven hypothesis // J. Clin. Endocrinol. Metab. — 2005. — P. 4970–4972.

[8] Circulating androgen levels and self-reported sexual function in women / Davis S. R. [et al.] // JAMA. — 2005. — Vol. 294. — P. 91–96.

[9] Conaglen H. M., Conaglen J. V. Sexual desire in women presenting for antiandrogen therapy // J. Sex. Marital. Ther. — 2003. — Vol. 29. — P. 255–267.

[10] Correlates of circulating androgens in mid-life women: the study of women’s health across the nation / Santoro N. [et al.] // J. Clin. Endocrinol. Metab. –2005. — Vol. 90. — P. 4836–4845.

[11] Davis S. R., Mijland E. A., Weijmar Schultz W. C. M. Tibolone vs transdermal continuous combined estrogen plus progestin in the treatment of female sexual dysfunction in naturally menopausal women: results from the LISA trial // Maturitas — 2006. — Vol. 554, suppl. — P. S1–112.

[12] Dawson S. J., Suschinsky K. D. Sexual fantasies and viewing times across the menstrual cycle: a diary study // Arch. Sex. Behav. — 2012— Vol. 41. — P. 173–183.

[13] Dehydroepiandrosterone replacement in women with adrenal insufficiency / Arlt W. [et al.] // N. Engl. J. Med. –1999. — Vol. 341. — P. 1013–1020.

[14] Dennerstein L., Lehert P., Burger H. The relative effects hormones and relationship factors on sexual function in women through the natural menopausal transition // Fertil. Steril. — 2005. — Vol. 84. — P. 1741–1780.

[15] Diamond L. M., Wallen K. Sexual minority women’s sexual motivation around the time of ovulation // Arch. Sex. Behav. — 2011. — Vol. 40. — P. 237–246.

[16] Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenstrual women / Archer J. S. [et al.] // Menopause. — 2006. — Vol. 13. — P. 528–537.

[17] Effects of menstrual cycle phase on face preferences / Jones B. C. [et al.] // Arch. Sex. Behav. — 2008. — Vol. 37. — P. 78–84.

[18] Ellis B. J., Symon D. Sex differences in sexual fantasy: an revolutionary psychological approach // Journal of Sexual Research. — 1990. — Vol. 27. — P. 527–555.

[19] Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone / Labrie F. [et al.] // Endocr. Rev. — 2003. — Vol. 24. — P. 152–182.

[20] Female androgen insufficiency: the Princeton consensus stateman of definition, classification, and assessment / Bachmann G. [et al.] // Fertility and Sterility — 2002. — Vol.77. — P. 660–665.

[21] Gender differences in the prevalence, clinical feature sand response to cabergoline in hyperprolactinemia / Coloa A. [et al.] // Eur. J. Endocrinol. — 2003. — Vol. 148. — P. 325–331.

[22] Genetic and environmental effects on same-sex sexual dehavior: a population study on twins in Sweden / Langstrom N. [et al.] // Arch. Sex. Behav. — 2010. — Vol. 39. — P. 75–80.

[23] Goeretzleher G. The role of progestogens in hormone replacement // Drugs of Today. — 2001. — Vol. 37, suppl. G. — P. 1–8.

[24] Graham J., Clarke C. Physiological action of progesterone in target tissue // Endocrine J. Reviews. — 1997. — Vol. 18. — P. 502–515.

[25] Hall P. A., Schaeff C. M. Sexual orientation and fluctuating asymmetry in men and women // Arch. Sex. Behav. — 2008. — P. 158–165.

[26] Hines M., Brook C., Conway G. S. Androgen and psychosexual: core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAN) // J. Sex. Res. — 2004. — Vol. 41. — P. 75–81.

[27] Hypoactive sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and Sexuality. (WISHeS) / Leiblum S. R. [et al.] // Menopause. — 2006. — Vol. 13. — P. 46–56.

[28] Krassas G. Thyroid disease and female reproduction // Fertil. Steril. — 2000. — Vol. 74. — P. 1063–1070.

[29] Lunsen R. H. van, Laan E. Genital vascular responsiveness in sexual feelings in midlife women: psychophysiologic, brain, and genital imaging studies // Menopause. — 2004. — Vol. 11. — P. 741–748.

[30] Menopausal symptoms in older women and the effects of treatment with hormone therapy / Barnabei V. M. [et al.] // Obstet. Gynaecol. — 2002. — Vol. 100. — P. 1209–1218.

[31] Miller S. S., Hoffmann H. L., Mustanski B. S. Fluctuating asymmetry and sexual orientation in men and women // Arch. Sex. Behav. — 2008. — Vol. 37. — P. 150–157.

[32] Motofei I. G., Rowland D. I. The physiological basis of human sexual arousal: neuroendocrine sexual asymmetry // Int. J. Androl. — 2005. — Vol. 28. — P. 78–87.

[33] North American Menopause Society. The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society // Menopause. — 2005. — Vol. 12. — P. 497–511.

[34] Ott M. A., Shew M. L., Ofner S. The influence of hormonal contraception on mood and sexual interest among adolescents // Arch. Sex. Behav. — 2008. — Vol. 37. — P. 605–613.

[35] Performance characteristics of a noval tandem mass spectrometry assay for serum testosterone / Kushnir M. M. [et al.] // Clin. Chem. — 2006. — Vol. 52. — P. 120–128.

[36] Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being / Aziz A. [et al.] // Fertil. Steril. — 2005. — Vol.83. — P. 1021–1028.

[37] Pharmacokinetics and pharmacodynamics efficacy of testosterone intranasal gel in women with hypoactive sexual desire and anorgasmia/Gorsel H. [et al.] // Program book ISSWSWH 2012 Annual Meeting “Eros in Eden”. — Jerusalem, 2012. — P. 96. http: // www.isswsh.org (дата обращения 23.09.2013).

[38] Portman D., Simon J., Goldstein S. Safety and efficacy of ospemifene, a selective estrogen receptor modulator, for treatment of postmenopausal women with vulvovaginal atrophy // Program book ISSWSWH 2012 Annual Meeting “Eros in Eden”. — Jerusalem. — 2012. — P. 95. http: // www.isswsh.org

[39] Prenatal sex hormones (maternal and amniotic fluid) and gender-related play behavior in 13-month-old infant/Beek C. [et al.] // Arch. Sex. Behav. — 2009. — Vol. 38. — P. 6–15.

[40] Provost M. P., Quinsey V. I., Troje N. F. Differences in gait across the menstrual cycle and their attractiveness to men // Arch. Sex. Behav. — 2008. — Vol. 37. — P. 598–604.

[41] Psychosexual outcome in women effected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency / Wisniewaski A. [et al.] // J. Urol. — 2004. — Vol. 171. — P. 2497–2501.

[42] Quality of life, psychosocial well-being and sexual satisfaction in women with polycystic ovary syndrome / Elsenbruch S. [et al.] // J. Clin. Endocrinol. Metab. — 2003. — Vol. 88. — P. 5801–5807.

[43] Rahman Q., Cockburn A., Govier E. A comparative analysis of functional cerebral asymmetry in lesbian women, heterosexual women and heterosexual men // Arch. Sex. Behav. — 2008. — Vol. 37. — P. 566–571.

[44] Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial / Braunshtein G. D. [et al.] // Arch. Intern. Med. — 2005. — Vol. 165. — P. 1582–1589.

[45] Sexual dysfunction in men and women with endocrine disorders / Bhasin S. [et al.] // Lancet. — 2007. — Vol. 369. — P. 597–611.

[46] Sexual dysfunction in women with hyperprolactinemia: a pilot study report / Kadioglu P. [et al.] // J. Urol. 2005. — Vol. 74. — P. 1921–1925.

[47] Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess / Meyer-Bahlburg H. F. L. [et al.] // Arch. Sex. Behav. — 2008. — Vol. 37. — P. 85–99.

[48] Sherwin B. B., Gelfand M. M., Brender W. Androgen enchances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause // Psychosomatic Medicine. — 1985. — Vol. 47. — P. 339–351.

[49] Sherwin B. B. Changes in sexual behavior as a function of plasma sex steroid levels in post-menopausal women // Maturitas. — 1985. — Vol. 7. — P. 225–233.

[50] Sherwin B. B., Gelfand M. M. The role of androgen in the maintenance of sexual functioning in oophorectomized women // Psychosomatic Medicine. — 1987. — Vol. 49. — P. 397–409.

[51] Snabes M. C., Simes S., Zborovski J. A clear pathway to approval for libigel treatment of postmenopausal women with hypoactive sexual desire disorders // Program book ISSWSWH 2012 Annual Meeting “Eros in Eden”. — Jerusalem, 2012. — P. 96–97. http://www.isswsh.org (дата обращения 23.09.2013).

[52] SOGC clinical practice guideline: Canadian consensus on menopausal update / Belisly S. [et al.] // J. Obstet. Gynaecol. Can. — 2006. — Vol. 172. — P. 43–52.

[53] Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids / Dayal M. [et al.] // J. Women Health. — 2005. — Vol. 14. — P. 391–400.

[54] Testosterone for peri- and postmenopausal women/Somboonporn W. [et al.] // Cochrane Database Syst. Rev. — 2005. — Vol. 4. — CD004509

[55] Testosterone patch for low sexual desire in surgically menopausal women a randomized trial / Buster J. E. [et al.] // Obstet. Gynecol. — 2005. — Vol.105. — P. 944–952.

[56] Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results of the Intimate NMI study / Shifren J. L. [et al.] // Menopause. — 2006. — Vol. 13. — P. 770–779.

[57] Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorders / Simon J. [et al.] // J. Clin. Endocrinol. Metab. — 2005. — Vol. 90. — P. 5226–5233.

[58] The efficacy and safety of a testosterone panch for the treatment of hypoactive sexual desire disorders in surgically menopausal women / Davis S. R. [et al.] // Menopause. — 2006. — Vol. 13. — P. 387–396.

[59] The North American Menopause Society. Amended report from the NAMS Advisory Panel on Postmenopausal Hormonal Therapy // Menopause. — 2003. — Vol. 10. — P. 6–12.

[60] Time course of effects of testosterone administration of sexual arousal in women / Tuitan A. [et al.] // Arch. Gen. Psychiatry. — 2000. — Vol. 57. — P. 149–153.

[61] Uytfanghe K van., Sticki D., Kaufman J. M. Evaluation of a candidate reference measurement procedure for serum free testosterone based on ultrafiltration and isotope dilution-gas chromatography-mass spectrometry // Clin. Chem. — 2004. — Vol. 50. — P. 2101–2110.

[62] Weiner C. L., Primeau M., Ehrmann D. A. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls // Psyhosom Med. — 2004. — Vol. 66. — P. 356–362.

RIGHTS & PERMISSIONS

Fedorova A.I.